Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment

Medical Care

Volumn 43, Issue 2, 2005, Pages 141-148

  Elmore, Joann G ^a,e   Nakano, Connie Y ^a   Linden, Hannah M ^a   Reisch, Lisa M ^a   Ayanian, John Z ^b,c   Larson, Eric B ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Health disparities; Race and ethnicity; Socioeconomic factors

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER SCREENING; CANCER THERAPY; COHORT ANALYSIS; DATA ANALYSIS; ECHOMAMMOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT CARE; RACE DIFFERENCE; SCREENING TEST;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSURANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 13544269268     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200502000-00007     Document Type: Article

References (50)

1. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
2. Brawley OW. Some perspective on black-white cancer statistics. CA Cancer J Clin. 2002;52:322-325.
3. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
4. Chu KC, Lamar CA, Freeman HP. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer. 2003;97:2853-2860.
5. Ries L, Eisner M, Kosary C. Cancer Statistics Review, 1973-1997. National Cancer Institute; 2000. Available at: http://seer.cancer.gov/csr/ 1973_1997/. Accessed November 17, 2004.
6. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
7. Hunter CP, Redmond CK, Chen VW, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst. 1993;85:1129-1137.
8. Jones BA, Kasl SV, Curnen MGM, et al. Can mammography screening explain the race difference in stage at diagnosis of breast cancer. Cancer. 1995;75:2103-2113.
9. Moormeier J. Breast cancer in black women. Ann Intern Med. 1996; 124:897-905.
10. Eley J, Hill H, Chen V, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
11. Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for medicare beneficiaries. Cancer. 1997;79:314-319.
12. Stanford J, Greenberg R. Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health. 1989;79:71-73.
13. Gapstur SM, Dupuis J, Gann P, et al. Hormone receptor status of breast tumors in black, Hispanic, and Non-Hispanic white women. An Analysis of 13,239 Cases. Cancer. 1996;77:1465-1471.
14. Ownby HE, Frederick J, Russo J, et al. Racial differences in breast cancer patients. J Natl Cancer Inst. 1985;75:55-60.
15. Elmore JG, Moceri VM, Carter D, et al. Breast carcinoma tumor characteristics in black and white women. Cancer. 1998;83:2509-2515.
16. Chen V, Correa P, Kurman R, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994;3:127-135.
17. Ayanian JZ, Kohler BA, Abe T, et al. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:2039-2040.
18. Lannin DR, Mathews HF, Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279:1801-1807.
19. Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team. Am J Prev Med. 1993;9:133-138.
20. Mandelblatt JS, Kerner JF, Hadley J, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer. 2002;95:1401-1414.
21. Qureshi M, Thacker HL, Litaker DG, et ak. Differences in breast cancer screening rates: an issue of ethnicity or socioeconomics? J Womens Health Gend Based Med. 2000;9:1025-1031.
22. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91:1409-1415.
23. Figueroa JB, Breen N. Significance of underclass residence on the stage of breast or cervical cancer diagnosis. Am Econ Rev. 1995;85:112-116.
24. McGinnis LS, Menck HR, Eyre HJ, et al. National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer. 2000;88:933-945.
25. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490-496.
26. Bradley CJ, Given CW, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care. 2003;41:722-728.
27. Friedman C, Ahmed F, Franks A, et al. Association between health insurance coverage of office visit and cancer screening among women. Med Care. 2002;40:1060-1067.
28. Lee-Feldstein A, Feldstein PJ, Buchmueller T, et al. The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes. Med Care. 2000;38:705-718.
29. Haas JS, Phillips KA, Sonneborn D, et al. Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care. 2002;40:743-751.
30. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134-147.
31. Kerner JF, Yedidia M, Padgett D, et al. Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med. 2003;37:92-101.
32. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
33. SAS Institute Inc. SAS System for Windows V8. 8 ed. Cary, NC; SAS Institute; 1999-2001.
34. American Cancer Society. American Cancer Society Home Page. Available at: http://www.cancer.org/docroot/PED/content/PED_2_3X_ Chronological_History_of_ACS_Recommendations_on_Early_Detection_ of_Cancer.asp?sitearea=PED. Accessed November 17, 2004.
35. Braveman P, Cubbin C, Marchi KS, et al. An Approach to policy-oriented monitoring of equity in health, The 130th Annual Meeting of the American Public Health Association. Philadelphia, PA; Nov. 9-13, 2002.
36. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
37. Centers for Disease Control and Prevention. Strategies for providing follow-up and treatment services in the National Breast and Cervical Cancer Eearly Detection Program-United States. JAMA. 1998;279:1941-1942.
38. Henson RM, Wyatt SW, Lee NC. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women. J Public Health Manage Pract. 1996;2:36-47.
39. Burns R, McCarthy E, Freund K, et al. Black women receive less mammography even with similar use of primary care. Ann Intern Med. 1996;125:173-182.
40. Chang S, Kerlikowske K, Napoles-Springer A, et al. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996;78:1395-1402.
41. Everson SA, Goldberg DE, Kaplan GA, et al. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med. 1996;58:113-121.
42. Fentiman I. Pensive women, painful vigils: consequences of delay in assessment of mammographic abnormalities. Lancet. 1988;1:1041-1042.
43. Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res. Treatment. 1996;40:53-64.
44. Roach M 3rd, Cirrincione C, Budman D, et al. Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am. 1997;3:107-112.
45. Dignam JJ, Redmond CK, Fisher B, et al. Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer. 1997;80: 80-90.
46. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin. 2000;50:50-64.
47. Heimann R, Ferguson D, Powers C, et al. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997;15:2329-2337.
48. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer 1996;78:1241-1247.
49. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999;91:1487-1491.
50. Smedley BD. Unequal Treatment: What Healthcare Providers Need to Know About Racial and Ethnic Disparities in Health Care. Institute of Medicine. Available at: http://www.iom.edu/includes/dbfile.asp?id=4175. Accessed November 17, 2004.